Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Bcworldpharm Co's Pretax Margin % or its related term are showing as below:
XKRX:200780'
s Pretax Margin % Range Over the Past 10 Years
Min: -4.99 Med: -2.51 Max: 17.07
Current: -0.97
XKRX:200780's Pretax Margin % is ranked worse than 67.26% of 962
companies
in the Drug Manufacturers industry
Industry Median: 7.155
vs XKRX:200780: -0.97
Bcworldpharm Co (XKRX:200780) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Bcworldpharm Co Pretax Margin % Related Terms
Bcworldpharm Co Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Bcworldpharm Co's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:200780 vs LLY, JNJ, ABBV: Pretax Margin % Comparison
For the Drug Manufacturers - General subindustry, Bcworldpharm Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bcworldpharm Co Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bcworldpharm Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Bcworldpharm Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bcworldpharm Co (XKRX:200780) has a Pretax Margin % of -5.86% as of Jun. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Bcworldpharm Co and its competitors. According to the industry distribution chart, Bcworldpharm Co ranks #647 out of 962 companies in the Drug Manufacturers industry, placing it in the top 67.3%.
Is Bcworldpharm Co's Pretax Margin % too high?
Bcworldpharm Co's current Pretax Margin % is -5.86%. Based on the distribution chart, Bcworldpharm Co ranks #647 out of 962 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Bcworldpharm Co has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bcworldpharm Co's Pretax Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Bcworldpharm Co ranks #647 out of 962 companies for Pretax Margin %. This places Bcworldpharm Co in the lower half of its industry. The industry median Pretax Margin % is 7.16. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.16, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Bcworldpharm Co and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bcworldpharm Co's current Pretax Margin % is -5.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bcworldpharm Co stock overvalued right now?
Based on GuruFocus' analysis, Bcworldpharm Co (XKRX:200780) is currently considered Possible Value Trap. The stock's GF Value™ is ₩5,477.85, compared to a current price of ₩3,040.00 — trading 44.5% below its estimated fair value. The current Pretax Margin % is -5.86%. Bcworldpharm Co's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Bcworldpharm Co (XKRX:200780), the current Pretax Margin % is -5.86% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bcworldpharm Co (XKRX:200780) Overvalued in 2026?
Based on GuruFocus' analysis, Bcworldpharm Co stock appears to be undervalued.
The current stock price of ₩3,040.00 is trading 44.5% below its estimated GF Value™ of ₩5,477.85.
GuruFocus considers Bcworldpharm Co to be Possible Value Trap.
Key valuation signals for XKRX:200780:
Pretax Margin %: -5.86%
GF Value™: ₩5,477.85 vs. price of ₩3,040.00 (44.5% below fair value)
No single metric tells the full story. See the XKRX:200780 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bcworldpharm Co Ltd is a pharmaceutical company. The company is engaged in research and develop new and improved drugs through R&D and technological innovation. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics.
66GF Score
Get the complete analysis for XKRX:200780
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:200780 has been successfully added to your 
